Literature DB >> 24651007

The AML salad bowl.

Jesús Duque-Afonso1, Michael L Cleary2.   

Abstract

Tumors arise from single cells but become genetically heterogeneous through continuous acquisition of somatic mutations as they progress. In this issue of Cancer Cell, Klco and colleagues used whole genome sequence analysis to demonstrate the correlation of genetic clonal architecture with functional heterogeneity in acute myeloid leukemia.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2014        PMID： 24651007      PMCID： PMC4010182          DOI： 10.1016/j.ccr.2014.03.002

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  10 in total

Review 1.  The mighty mouse: genetically engineered mouse models in cancer drug development.

Authors:  Norman E Sharpless; Ronald A Depinho
Journal:  Nat Rev Drug Discov       Date:  2006-08-18       Impact factor: 84.694

2.  Functional heterogeneity of genetically defined subclones in acute myeloid leukemia.

Authors:  Jeffery M Klco; David H Spencer; Christopher A Miller; Malachi Griffith; Tamara L Lamprecht; Michelle O'Laughlin; Catrina Fronick; Vincent Magrini; Ryan T Demeter; Robert S Fulton; William C Eades; Daniel C Link; Timothy A Graubert; Matthew J Walter; Elaine R Mardis; John F Dipersio; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-06       Impact factor: 31.743

3.  Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.

Authors:  Nicolas Goardon; Emanuele Marchi; Ann Atzberger; Lynn Quek; Anna Schuh; Shamit Soneji; Petter Woll; Adam Mead; Kate A Alford; Raj Rout; Salma Chaudhury; Amanda Gilkes; Steve Knapper; Kheira Beldjord; Suriya Begum; Susan Rose; Nicola Geddes; Mike Griffiths; Graham Standen; Alexander Sternberg; Jamie Cavenagh; Hannah Hunter; David Bowen; Sally Killick; Lisa Robinson; Andrew Price; Elizabeth Macintyre; Paul Virgo; Alan Burnett; Charles Craddock; Tariq Enver; Sten Eirik W Jacobsen; Catherine Porcher; Paresh Vyas
Journal:  Cancer Cell       Date:  2011-01-18       Impact factor: 31.743

4.  Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways.

Authors:  Lüder Hinrich Meyer; Sarah Mirjam Eckhoff; Manon Queudeville; Johann Michael Kraus; Marco Giordan; Jana Stursberg; Andrea Zangrando; Elena Vendramini; Anja Möricke; Martin Zimmermann; Andre Schrauder; Georgia Lahr; Karlheinz Holzmann; Martin Schrappe; Giuseppe Basso; Karsten Stahnke; Hans Armin Kestler; Geertruy Te Kronnie; Klaus-Michael Debatin
Journal:  Cancer Cell       Date:  2011-02-03       Impact factor: 31.743

5.  Tumour evolution inferred by single-cell sequencing.

Authors:  Nicholas Navin; Jude Kendall; Jennifer Troge; Peter Andrews; Linda Rodgers; Jeanne McIndoo; Kerry Cook; Asya Stepansky; Dan Levy; Diane Esposito; Lakshmi Muthuswamy; Alex Krasnitz; W Richard McCombie; James Hicks; Michael Wigler
Journal:  Nature       Date:  2011-03-13       Impact factor: 49.962

6.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

7.  Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.

Authors:  Sohrab P Shah; Ryan D Morin; Jaswinder Khattra; Leah Prentice; Trevor Pugh; Angela Burleigh; Allen Delaney; Karen Gelmon; Ryan Guliany; Janine Senz; Christian Steidl; Robert A Holt; Steven Jones; Mark Sun; Gillian Leung; Richard Moore; Tesa Severson; Greg A Taylor; Andrew E Teschendorff; Kane Tse; Gulisa Turashvili; Richard Varhol; René L Warren; Peter Watson; Yongjun Zhao; Carlos Caldas; David Huntsman; Martin Hirst; Marco A Marra; Samuel Aparicio
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

8.  Genetic variegation of clonal architecture and propagating cells in leukaemia.

Authors:  Kristina Anderson; Christoph Lutz; Frederik W van Delft; Caroline M Bateman; Yanping Guo; Susan M Colman; Helena Kempski; Anthony V Moorman; Ian Titley; John Swansbury; Lyndal Kearney; Tariq Enver; Mel Greaves
Journal:  Nature       Date:  2010-12-15       Impact factor: 49.962

9.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

10.  Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.

Authors:  Liran I Shlush; Sasan Zandi; Amanda Mitchell; Weihsu Claire Chen; Joseph M Brandwein; Vikas Gupta; James A Kennedy; Aaron D Schimmer; Andre C Schuh; Karen W Yee; Jessica L McLeod; Monica Doedens; Jessie J F Medeiros; Rene Marke; Hyeoung Joon Kim; Kwon Lee; John D McPherson; Thomas J Hudson; Andrew M K Brown; Fouad Yousif; Quang M Trinh; Lincoln D Stein; Mark D Minden; Jean C Y Wang; John E Dick
Journal:  Nature       Date:  2014-02-12       Impact factor: 69.504
  10 in total
  9 in total

Review 1.  Classification and risk assessment in AML: integrating cytogenetics and molecular profiling.

Authors:  Matahi Moarii; Elli Papaemmanuil
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

2.  Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34+ Acute Myeloid Leukemia.

Authors:  Yan-Yu Wang; Wen-Lian Chen; Xiang-Qin Weng; Yan Sheng; Jing Wu; Jie Hao; Zhan-Yun Liu; Yong-Mei Zhu; Bing Chen; Shu-Min Xiong; Yu Chen; Qiu-Sheng Chen; Hui-Ping Sun; Jun-Min Li; Jin Wang
Journal:  Stem Cells Dev       Date:  2017-09-21       Impact factor: 3.272

3.  Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse.

Authors:  Zinaida Good; Jolanda Sarno; Astraea Jager; Nikolay Samusik; Nima Aghaeepour; Erin F Simonds; Leah White; Norman J Lacayo; Wendy J Fantl; Grazia Fazio; Giuseppe Gaipa; Andrea Biondi; Robert Tibshirani; Sean C Bendall; Garry P Nolan; Kara L Davis
Journal:  Nat Med       Date:  2018-03-05       Impact factor: 53.440

4.  MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.

Authors:  Athalia Rachel Pyzer; Dina Stroopinsky; Hasan Rajabi; Abigail Washington; Ashujit Tagde; Maxwell Coll; Jacqueline Fung; Mary Paty Bryant; Leandra Cole; Kristen Palmer; Poorvi Somaiya; Rebecca Karp Leaf; Myrna Nahas; Arie Apel; Salvia Jain; Malgorzata McMasters; Lourdes Mendez; James Levine; Robin Joyce; Jon Arnason; Pier Paolo Pandolfi; Donald Kufe; Jacalyn Rosenblatt; David Avigan
Journal:  Blood       Date:  2017-01-26       Impact factor: 22.113

Review 5.  Mouse models for core binding factor leukemia.

Authors:  D W L Chin; N Watanabe-Okochi; C Q Wang; V Tergaonkar; M Osato
Journal:  Leukemia       Date:  2015-07-13       Impact factor: 11.528

6.  Thioridazine requires calcium influx to induce MLL-AF6-rearranged AML cell death.

Authors:  Claudia Tregnago; Ambra Da Ros; Elena Porcù; Maddalena Benetton; Manuela Simonato; Luca Simula; Giulia Borella; Katia Polato; Sonia Minuzzo; Giulia Borile; Paola Cogo; Silvia Campello; Alessandro Massi; Romeo Romagnoli; Barbara Buldini; Franco Locatelli; Martina Pigazzi
Journal:  Blood Adv       Date:  2020-09-22

7.  Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemia.

Authors:  Cong Yu; Qing-lei Kong; Yun-xiang Zhang; Xiang-qin Weng; Jing Wu; Yan Sheng; Chun-lei Jiang; Yong-mei Zhu; Qi Cao; Shu-min Xiong; Jun-min Li; Xiao-dong Xi; Sai-juan Chen; Bing Chen
Journal:  J Hematol Oncol       Date:  2015-05-10       Impact factor: 17.388

8.  Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencing.

Authors:  AiLi Chen; ShaoYan Hu; Qian-Fei Wang
Journal:  Blood Sci       Date:  2019-09-17

9.  Immunosuppressive role of CD11b+ CD33+ HLA-DR- myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia.

Authors:  Shin Young Hyun; Eun Jung Na; Ji Eun Jang; Haerim Chung; Soo Jeong Kim; Jin Seok Kim; Jee Hyun Kong; Kwang Yong Shim; Jong In Lee; Yoo Hong Min; June-Won Cheong
Journal:  Cancer Med       Date:  2020-08-11       Impact factor: 4.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.